Olive leaf extract put to the test against high blood pressure

NCT ID NCT05636826

Completed Disease control Sponsor: University of Monastir Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This trial investigates whether a daily dose of olive leaf extract (atherolive) can help control blood pressure and improve cholesterol levels in adults with hypertension. Participants are randomly assigned to receive either the extract or a placebo for three months. The study aims to see if this natural approach can be a safe and effective way to manage cardiovascular risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: olive leaf extract (atherolive)
What this could lead to: If effective, olive leaf extract could offer a natural option to help control blood pressure and cholesterol.
What could go wrong: This is a mid-stage trial; results may not confirm benefit, and natural supplements can vary in potency and purity.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERTENSION

Contacts and locations

Show contact details

Locations

University Hospital Fattouma Bourguiba Monastir

Monastir, Tunisia

More trials for these conditions

Other studies related to the condition(s) this trial covers.